ReviewNPJ precision oncology2025
Immune-checkpoint targeting drug conjugates: a novel class of promising therapeutic agents for cancer treatment.
Silvia Marchesi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this paperpooled itcites it